Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
How It Works in Your Body The injection spot can change how well the medication does its job
NICE has published guidance on pharmacological interventions for weight management, including NICE guideline CG189 (Obesity: identification, assessment and management) and a technology appraisal supporting the use of semaglutide (Wegovy) for adults with a BMI of 35 kg/m or above (or 3034.9 kg/m in certain circumstances) alongside a specialist weight management service
The potential for synergistic effects between semaglutide and other agents could offer new avenues for individuals who struggle to lose weight through diet, exercise, and monotherapy alone
This prevents discomfort at the site of injection
Data are shown through Week 51 (133 weeks of age)
If changing your regular injection day, ensure at least 72 hours between doses
